Preethi Korangath

2.4k total citations · 1 hit paper
42 papers, 1.5k citations indexed

About

Preethi Korangath is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Preethi Korangath has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Biomaterials. Recurrent topics in Preethi Korangath's work include Nanoparticle-Based Drug Delivery (11 papers), Cancer Cells and Metastasis (5 papers) and Cancer-related Molecular Pathways (4 papers). Preethi Korangath is often cited by papers focused on Nanoparticle-Based Drug Delivery (11 papers), Cancer Cells and Metastasis (5 papers) and Cancer-related Molecular Pathways (4 papers). Preethi Korangath collaborates with scholars based in United States, India and China. Preethi Korangath's co-authors include Robert Ivkov, Ramadasan Kuttan, Frederik Soetaert, Steven Fiering, David Serantes, Girija Kuttan, Saraswati Sukumar, R Kuttan, Wei Wen Teo and Girija Kuttan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and ACS Nano.

In The Last Decade

Preethi Korangath

40 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies

2020 295 citations Frederik Soetaert, Preethi Korangath et al. Advanced Drug Delivery Reviews profile →

Peers

Countries citing papers authored by Preethi Korangath

Since Specialization

Citations

This map shows the geographic impact of Preethi Korangath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Preethi Korangath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Preethi Korangath more than expected).

Fields of papers citing papers by Preethi Korangath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Preethi Korangath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Preethi Korangath. The network helps show where Preethi Korangath may publish in the future.

Co-authorship network of co-authors of Preethi Korangath

This figure shows the co-authorship network connecting the top 25 collaborators of Preethi Korangath. A scholar is included among the top collaborators of Preethi Korangath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Preethi Korangath. Preethi Korangath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Verification and Validation of an Autotuning Proportional–Integral–Derivative Controller for Spatially Confined Magnetic Particle Hyperthermia 2025 ·Journal of Medical Devices ·(unknown), (unknown), (unknown), (unknown), (unknown), Preethi Korangath, Robert Ivkov, Anilchandra Attaluri	0
2	Dendritic cell activation by iron oxide nanoparticles depends on the extracellular environment 2024 ·Nanoscale Advances ·M Song, Robert Ivkov, Preethi Korangath	1
3	Iron Oxide Nanoparticles Inhibit Tumor Progression and Suppress Lung Metastases in Mouse Models of Breast Cancer 2024 ·ACS Nano ·Preethi Korangath, Lü Jin, Chun-Ting Yang, S. B. Healy, Xin Guo, (unknown), Cordula Grüttner, Chen Hu, Kathleen Gabrielson, Jeremy B. Foote, Robert Clarke, Robert Ivkov	19
4	Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer—a preclinical study 2022 ·Proceedings of the National Academy of Sciences ·Guannan Wang, (unknown), (unknown), Preethi Korangath, Tapan K. Bera, (unknown), Priya Pai, Kathleen Gabrielson, Ira Pastan, Saraswati Sukumar	14
5	A Predictive Pharmacokinetic Model for Immune Cell-Mediated Uptake and Retention of Nanoparticles in Tumors 2022 ·International Journal of Molecular Sciences ·(unknown), Chun-Ting Yang, Preethi Korangath, Robert Ivkov, Andris F. Bakuzis	8
6	Systemically delivered antibody-labeled magnetic iron oxide nanoparticles are less toxic than plain nanoparticles when activated by alternating magnetic fields 2020 ·International Journal of Hyperthermia ·Chun-Ting Yang, Preethi Korangath, (unknown), Chen Hu, Wei Fu, Cordula Grüttner, Sarah E. Beck, Feng‐Huei Lin, Robert Ivkov	3
7	Nanoparticle interactions with immune cells dominate tumor retention and induce T cell–mediated tumor suppression in models of breast cancer 2020 ·Science Advances ·Preethi Korangath, James D. Barnett, Anirudh Sharma, Elizabeth Henderson, Jacqueline Stewart, Shu-Han Yu, Sri Kamal Kandala, Chun-Ting Yang, Julia S. Caserto, Mohammad Hedayati, Todd D. Armstrong, Elizabeth M. Jaffee, Cordula Gruettner, Xian Zhou, Wei Fu, Chen Hu, Saraswati Sukumar, Brian W. Simons, Robert Ivkov	131
8	Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies breakdown → 2020 ·Advanced Drug Delivery Reviews ·Frederik Soetaert, Preethi Korangath, David Serantes, Steven Fiering, Robert Ivkov	295
9	Magnet-assisted Flow Cytometry of in vivo Tumors to Quantitate Cell-specific Responses to Magnetic Iron Oxide Nanoparticles 2020 ·BIO-PROTOCOL ·Preethi Korangath, Robert Ivkov	5
10	Increased uptake of doxorubicin by cells undergoing heat stress does not explain its synergistic cytotoxicity with hyperthermia 2019 ·International Journal of Hyperthermia ·Anirudh Sharma, (unknown), Julia S. Caserto, Rosemarie ten Cate, Nicole M. Anders, James D. Barnett, Sri Kamal Kandala, Elizabeth Henderson, Jacqueline Stewart, Eleni Liapi, Michelle A. Rudek, Nicolaas A.P. Franken, Arlene L. Oei, Preethi Korangath, Fred Bunz, Robert Ivkov	22
11	Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer 2019 ·International Journal of Hyperthermia ·Arlene L. Oei, Preethi Korangath, Kathleen R. Mulka, Mikko Helenius, Jonathan B. Coulter, Jacqueline Stewart, Esteban Velarde, Johannes Crezee, Brian W. Simons, Lukas J.A. Stalpers, H. Petra Kok, Kathleen L. Gabrielson, Nicolaas A.P. Franken, Robert Ivkov	46
12	Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles 2018 ·Scientific Reports ·Anirudh Sharma, Christine Cornejo, Jana Mihalic, Alison S. Geyh, David E. Bordelon, Preethi Korangath, Fritz Westphal, Cordula Gruettner, Robert Ivkov	57
13	Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast Cancer 2016 ·Cancer Research ·Vanessa F. Merino, Nguyen Nguyen, Kideok Jin, Helen Sadik, Soonweng Cho, Preethi Korangath, Liangfeng Han, (unknown), Xian Zhou, Zhe Zhang, Roisín M. Connolly, Vered Stearns, Syed Z. Ali, (unknown), Qian Chen, Duojia Pan, David L. Huso, Peter Ordentlich, Angela Brodie, Saraswati Sukumar	37
14	A Self-Folding Hydrogel In Vitro Model for Ductal Carcinoma 2016 ·Tissue Engineering Part C Methods ·Hye Rin Kwag, (unknown), Preethi Korangath, Saraswati Sukumar, Lewis H. Romer, David H. Gracias	41
15	HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance 2015 ·Cancer Discovery ·Kideok Jin, Sunju Park, Wei Wen Teo, Preethi Korangath, Soonweng Cho, Takahiro Yoshida, Balázs Győrffy, Chirayu Goswami, Harikrishna Nakshatri, (unknown), Weiqiang Zhou, Hongkai Ji, Ying Su, Muhammad B. Ekram, Zhengsheng Wu, Tao Zhu, Kornélia Polyák, Saraswati Sukumar	67
16	Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate 2015 ·Clinical Cancer Research ·Preethi Korangath, Wei Wen Teo, Helen Sadik, Liangfeng Han, Noriko Mori, (unknown), Flonné Wildes, Santosh Kumar Bharti, Zhe Zhang, Cesar A. Santa‐Maria, (unknown), Chi V. Dang, Vered Stearns, Zaver M. Bhujwalla, Saraswati Sukumar	133
17	The Notch Pathway Inhibits TGFβ Signaling in Breast Cancer through HEYL-Mediated Crosstalk 2014 ·Cancer Research ·Liangfeng Han, Adam Diehl, Nguyen K. Nguyen, Preethi Korangath, Wei Wen Teo, Soonweng Cho, Scott L. Kominsky, David L. Huso, Lionel Feigenbaum, Alan Rein, Pedram Argani, Göran Landberg, Manfred Gessler, Saraswati Sukumar	27
18	Effect of homeopathic medicines on Transplanted Tumors in mice 2010 ·Indian Journal of Research in Homoeopathy ·(unknown), Girija Kuttan, Preethi Korangath, Ramadasan Kuttan	24
19	Inhibition of Chemically Induced Carcinogenesis by Drugs Used in Homeopathic Medicine 2009 ·Indian Journal of Research in Homoeopathy ·(unknown), (unknown), Girija Kuttan, Preethi Korangath, (unknown), Ramadasan Kuttan	24
20	Wound healing activity of flower extract of Calendula offlcinalis 2009 ·Journal of Basic and Clinical Physiology and Pharmacology ·Preethi Korangath, R Kuttan	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact